Related Experiment Video
Updated: May 29, 2026
05:49
Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
[Antiphospholipid syndrome diagnosis: an update]
Benoit Visseaux1, Julien Masliah-Planchon, Anne-Marie Fischer
1Service d'hématologie biologique, Hôpital Européen Georges Pompidou, AP-HP, Paris.
Annales De Biologie Clinique
|September 8, 2011
Summary
Antiphospholipid syndrome (APS) diagnosis is complex. This overview examines recent advancements in detecting antiphospholipid antibodies (APAs), aiding in identifying this thrombosis and pregnancy complication disorder.
Area of Science:
- Immunology
- Hematology
- Obstetrics & Gynecology
Context:
- Antiphospholipid syndrome (APS) involves thrombosis and pregnancy issues linked to antiphospholipid antibodies (APAs).
- APA detection methods include lupus anticoagulant (LA) tests and ELISAs for anticardiolipin and anti-β2GPI antibodies.
- Diagnostic criteria were updated in 2006 to include anti-β2GPI antibodies and extend the testing interval to 12 weeks.
Purpose:
- To provide an overview of the latest diagnostic advancements for antiphospholipid syndrome (APS).
- To discuss the evolving landscape of antiphospholipid antibody (APA) detection and interpretation.
- To highlight the ongoing challenges in achieving a definitive APS diagnosis.
Summary:
- APS diagnosis relies on identifying specific autoantibodies, namely antiphospholipid antibodies (APAs).
- Key diagnostic markers include lupus anticoagulant (LA), anticardiolipin antibodies, and anti-β2-glycoprotein I (anti-β2GPI) antibodies.
- Recent updates emphasize anti-β2GPI antibodies and a prolonged interval between positive tests, yet diagnosis remains challenging.
Impact:
- Improved diagnostic accuracy for antiphospholipid syndrome (APS).
- Enhanced understanding of the role of specific antiphospholipid antibodies (APAs) in disease pathogenesis.
- Facilitation of timely and appropriate patient management for APS-related complications.
Related Concept Videos
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...